Transforming growth factor-β1 gene expression and cyclosporine A-induced gingival overgrowth: A pilot study

Journal of Clinical Periodontology

Volumn 35, Issue 5, 2008, Pages 371-378

  Radwan Oczko, Małgorzata ^a   Boratyńska, Maria ^a   Ziȩtek, Marek ^a   Dobosz, Tadeusz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Gingival overgrowth; Immunosuppression; Renal transplant; TGF 1 gene expression

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; GENE EXPRESSION; GENETICS; GINGIVA OVERGROWTH; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT STUDY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CYCLOSPORINE; FEMALE; GENE EXPRESSION; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 42149089329     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2008.01216.x     Document Type: Article

References (43)

1. Afonso, M., de Oliveira, V., Bello, V., Shibli, J. A. Sposto, M. R. (2003) Cyclosporin A-induced gingival overgrowth in renal transplant recipients. Journal of Periodontology 74, 51 56.
2. Aimetti, M., Romano, F. Debernardi, C. (2005a) Effectiveness of periodontal therapy on the severity of cyclosporin A-induced gingival overgrowth. Journal of Clinical Periodontology 32, 846 850.
3. Aimetti, M., Romano, F., Priotto, P. Debernardi, C. (2005b) Non-surgical periodontal therapy of cyclosporin A gingival overgrowth in organ transplant patients. Clinical results at 12 months. Minerva Stomatologica 54, 311 319.
4. Atilla, G. Kütükcüler, N. (1998) Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha and interleukin-6 levels in renal transplant patients receiving cyclosporine A. Journal of Periodontology 69, 784 790.
5. Ayanoglou, C. M. Lesty, C. (1999) Cyclosporin A-induced gingival overgrowth in the rat: a histological, ultrastructural and histomorphometric evaluation. Journal of Periodontal Research 34, 7 15.
6. Bartoli, F., Castronovo, G. Stabile, A. (2004) Risk factors conditioning the incidence and severity of cyclosporine A-induced gingival overgrowth and methods of prevention. Minerva Stomatologica 53, 165 170.
7. Berloco, P., Rossi, M., Pretagostini, R., Sociu-Foca, Cortesini, N. Cortesini, R. (2001) Tacrolimus as cornerstone immunosuppressant in kidney transplantation. Transplantation Proceedings 33, 994 996.
8. 1 level in crevicular fluid of cyclosporin A-treated patients. Journal of Periodontology 72, 526 531.
9. Busque, S., Demers, P., Saint-Louis, G., Boily, J. G., Tousignant, J., Lemieux, F., Martin, G., Smeesters, C., Corman, J. Daloze, P. (1999) Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporine by tacrolimus. Annales de Chirurgie 53, 687 689.
10. Chand, D. H., Southerland, S. M. Cunningham, R. J. (2001) Tacrolimus: the good, the bad and the ugly. Pediatric Transplant 5, 35 36.
11. 1 as a risk factor for gingival overgrowth. Journal of Clinical Periodontology 31, 863 868.
12. Guo, Z., Binswanger, U. Knoflach, A. (2002) Role of codon 10 and codon 25 polymorphisms on TGF-β1 gene expression and protein synthesis in stable renal allograft recipients. Transplantation Proceedings 34, 2904 2906.
13. Hernandez, G., Arriba, L., Cruz Frias, M., Macorra, J. C., Vicente, J. C., Jimenez, C., Andres, A. Moreno, E. (2003) Conversion from cyclosporin A to tacrolimus as non-surgical alternative to reduce gingival enlargement: a preliminary case series. Journal of Periodontology 74, 1816 1823.
14. 1 plasma levels in stable renal allograft recipients under different immunosuppression. Transplantation 4, 586 587.
15. Hoffmann, S. C., Stanley, E. M., Cox, E. D., Craighead, N., Di Mercurio, B. S., Koziol, D. E., Harlan, D. M., Kirk, A. D. Blair, P. J. (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72, 1444 1450.
16. Hughes, J. R., Hughes, V. F., Trull, A. Metcalfe, S. M. (1999) Blood levels of TGF-β1 in liver transplants recipients receiving either tacrolimus or micro-emulsified cyclosporine. Transplantation 4, 583 586.
17. 1. Journal of Periodontal Research 33, 40 48.
18. James, J. A., Jamal, S., Hull, P. S., Macfarlane, T. V., Campbell, B. A., Johnson, R. W. G. Short, C. G. (2001) Tacrolimus is not associated with gingival overgrowth in renal transplant patients. Journal of Clinical Periodontology 28, 848 852.
19. James, J. A., Marley, J. J., Jamal, S., Campbell, B. A., Short, C. D., Johnson, R. W. G., Hull, P. S., Spratt, H., Irwin, C. R., Boomer, S., Maxwell, A. P. Linden, G. J. (2000) The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. Journal of Clinical Periodontology 27, 109 115.
20. Kantarci, A., Cebeci, I., Tuncer, Ö., Carin, M. Firatli, E. (1999) Clinical effects of periodontal therapy on the severity of cyclosporin A-induced gingival hyperplasia. Journal of Periodontology 70, 587 593.
21. Khanna, A. K., Cairns, V. R., Becker, C. G. Hosenpud, J. D. (1999) Transforming growth factor (TGF)-β mimics and anti TGF-β antibody abrogates the in vivo effects of cyclosporine. Transplantation 67, 882 889.
22. Kohnle, M., Lülkes, P., Zimmermann, U., Philipp, T. Heemann, U. (1999) Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia. Transplantation Proceedings 31, 44 45.
23. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M. Karlson, S. (1993) Transforming growth factor beta 1null mutation in mice causes excessive inflammatory response and early death. Proceedings of the National Academy of Sciences of the United States of America 90, 770 777.
24. Lange, D. E., Plagmann, H. Ch., Eenboom, A. Prommesberger, A. (1977) Klinische bewertungsverfahren zur objektivierung der mundhygiene. Deutsche Zahnärztliche Zeitschrift 32, 44 46.
25. Leung, W. K., Yau, J. Y. Y., Jin, L. J., Chan, A. W. K., Chu, F. C. S., Tsang, C. S. P Chan, T. M. (2003) Subgingival microbiota of renal transplant recipients. Oral Microbiology and Immunology 18, 37 44.
26. Mariani, G., Calastrini, C., Carinci, F., Bergamini, L., Calastrini, F. Stabellini, G. (1996) Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. Journal of Periodontology 67, 21 27.
27. Modeer, T., Wondimu, B., Larsson, E. Jonzon, B. (1992) Levels of cyclosporin A (CsA) in saliva in children after oral administration of the drug in mixture or in capsule form. Scandinavian Journal of Dental Research 100, 366 370.
28. Mühlemann, H. R. Son, S. (1971) Gingival sulcus bleeding - a leading symptom in initial gingivitis. Helvetica Odontologica Acta 15, 107 111.
29. Nurmenniemi, P. K., Pernu, H. E. Knuuttila, M. L. E. (2001) Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. Journal of Periodontology 72, 167 173.
30. Ochsner, S., Guo, Z., Binswanger, U. Knoflach, A. (2002) TGF-β1 gene expression in stable renal transplant recipients: influence of TGF-β1 gene polymorphism and immunosuppression. Transplantation Proceedings 34, 2901 2903.
31. O'Valle, F., Mesa, F., Aneiros, J., Gomez-Morales, M., Lucena, M. A., Ramirez, C., Revelles, F., Moreno, E., Navarro, N., Caballero, T., Masseroli, M. Garcia del Moral, R. (1995) Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis. Journal of Clinical Periodontology 22, 591 597.
32. Qin, L., Chavin, K. D., Ding, Y., Woodward, J. E., Favaro, J. P., Lin, J. Bromberg, J. S. (1994) Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor beta 1. Annals of Surgery 220, 508 513.
33. Radwan-Oczko, M. Boratyńska, M. (2006) The influence of different treatment modalities on clinical improvement and reduction of cyclosporine A-induced gingival overgrowth. Case Report and Clinical Practice Review 7, 58 63.
34. Radwan-Oczko, M., Boratyńska, M., Klinger, M. Ziȩtek, M. (2003) Risk factors in kidney transplant recipients treated with cyclosporine A. Annals of Transplantation 8, 40 45.
35. Radwan-Oczko, M., Boratyńska, M. Ziȩtek, M. (2004) Clinical evaluation of marginal parodontium condition in patients after kidney graft treated with calcineurine inhibitors and calcium channel blockers. Bulletin du Groupement Européen Pour la Recherche Scientifique en Stomatologie et Odontologie 46, 45 51.
36. Radwan-Oczko, M., Boratyńska, M., Ziȩtek, M., Żołȩdziewska, M. Jonkisz, A. (2006) The relationship of transforming growth factor-beta 1 gene polymorphism, its plasma level and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. Journal of Periodontology 77, 865 873.
37. Routray, S. N., Mishra, T. K., Pattnaik, U. K., Satapathy, C., Mishra, C. K. Behera, M. (2003) Amlodipine-induced gingival hyperplasia. Journal of The Association of Physicians of India 51, 818 819.
38. 1 in humans. Transplantation 65, 313 318.
39. Thomas, D. W., Newcombe, R. G. Osborne, G. R. (2000) Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 69, 522 526.
40. Thorp, M., De Mattos, A., Bennett, W., Barry, J. Norman, D. (2000) The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutyzm and cholesterol. Transplantation 69, 1218 1224.
41. Werner, S. Grose, R. (2003) Regulation of wound healing by growth factors and cytokines. Physiological Reviews 83, 835 870.
42. Wright, H. J., Chapple, I. L., Blairm, F. Matthews, J. B. (2004) Crevicular fluid levels of TGF beta 1 in drug-induced gingival overgrowth. Archives of Oral Biology 49, 421 425.
43. Wright, H. J., Chapple, I. L. Matthews, J. B. (2000) TGF-β isoforms and TGF-β receptors in drug-induced and hereditary gingival overgrowth. Journal of Oral Pathology and Medicine 30, 281 289.